Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 289

1.

Advances and limitations of drug delivery systems formulated as eye drops.

Jumelle C, Gholizadeh S, Annabi N, Dana R.

J Control Release. 2020 Feb 3;321:1-22. doi: 10.1016/j.jconrel.2020.01.057. [Epub ahead of print] Review.

PMID:
32027938
2.

A standardized methodology for longitudinal assessment of corneal endothelial morphometry in eye banked corneas.

Lu┼żnik Z, Sun Z, Yin J, Benetz BA, Lass JH, Dana R.

J Biol Methods. 2019 Nov 20;6(4):e120. doi: 10.14440/jbm.2019.304. eCollection 2019.

3.

Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection.

Tahvildari M, Inomata T, Amouzegar A, Dana R.

Curr Ophthalmol Rep. 2018 Dec;6(4):266-274. Epub 2018 Oct 6.

4.

Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application.

Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A.

JAMA Ophthalmol. 2019 Nov 27. doi: 10.1001/jamaophthalmol.2019.4815. [Epub ahead of print]

PMID:
31774457
5.

Letter From the New Editor-in-Chief.

Dana R.

Cornea. 2020 Jan;39(1):1. doi: 10.1097/ICO.0000000000002231. No abstract available.

PMID:
31764283
6.

Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases.

Tahvildari M, Dana R.

J Immunol. 2019 Dec 1;203(11):2749-2755. doi: 10.4049/jimmunol.1900733.

PMID:
31740549
7.

Authors' Response.

Szczotka-Flynn LB, Maguire MG, Ying GS, Lin MC, Bunya VY, Dana R, Asbell PA; Dry Eye Assessment and Management (DREAM) Study Research Group.

Optom Vis Sci. 2019 Nov;96(11):892. doi: 10.1097/OPX.0000000000001450. No abstract available.

PMID:
31688696
8.

Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation.

Yu M, Lee SM, Lee H, Amouzegar A, Nakao T, Chen Y, Dana R.

Am J Pathol. 2020 Jan;190(1):125-133. doi: 10.1016/j.ajpath.2019.09.020. Epub 2019 Oct 24.

PMID:
31669306
9.

Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10.

Coco G, Foulsham W, Nakao T, Yin J, Amouzegar A, Taketani Y, Chauhan SK, Dana R.

Am J Transplant. 2020 Feb;20(2):389-398. doi: 10.1111/ajt.15631. Epub 2019 Oct 30.

PMID:
31587452
10.

Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.

Pflugfelder SC, Massaro-Giordano M, Perez VL, Hamrah P, Deng SX, Espandar L, Foster CS, Affeldt J, Seedor JA, Afshari NA, Chao W, Allegretti M, Mantelli F, Dana R.

Ophthalmology. 2020 Jan;127(1):14-26. doi: 10.1016/j.ophtha.2019.08.020. Epub 2019 Aug 26.

11.

Reply.

Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, Shimmura S, Kruse FE.

Cornea. 2019 Dec;38(12):e56-e57. doi: 10.1097/ICO.0000000000002145. No abstract available.

PMID:
31517726
12.

Management of meibomian gland dysfunction: a review.

Sabeti S, Kheirkhah A, Yin J, Dana R.

Surv Ophthalmol. 2020 Mar - Apr;65(2):205-217. doi: 10.1016/j.survophthal.2019.08.007. Epub 2019 Sep 5. Review.

PMID:
31494111
13.

Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study.

Roy NS, Wei Y, Yu Y, Ying GS, Kuklinski E, Barry B, Maguire MG, Dana R, Brightwell-Arnold M, Asbell PA; for the Dry Eye Assessment and Management (DREAM) Study Group.

Transl Vis Sci Technol. 2019 Aug 21;8(4):31. doi: 10.1167/tvst.8.4.31. eCollection 2019 Jul.

14.

Insights into estuary habitat loss in the western United States using a new method for mapping maximum extent of tidal wetlands.

Brophy LS, Greene CM, Hare VC, Holycross B, Lanier A, Heady WN, O'Connor K, Imaki H, Haddad T, Dana R.

PLoS One. 2019 Aug 14;14(8):e0218558. doi: 10.1371/journal.pone.0218558. eCollection 2019.

15.

Keratoconus progression associated with hormone replacement therapy.

Coco G, Kheirkhah A, Foulsham W, Dana R, Ciolino JB.

Am J Ophthalmol Case Rep. 2019 Jul 16;15:100519. doi: 10.1016/j.ajoc.2019.100519. eCollection 2019 Sep.

16.

Limbal and Conjunctival Epithelial Thickness in Ocular Graft-Versus-Host Disease.

Kheirkhah A, Coco G, Satitpitakul V, Pham TT, Dana R.

Cornea. 2019 Oct;38(10):1286-1290. doi: 10.1097/ICO.0000000000002066.

PMID:
31306282
17.

The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection.

Foulsham W, Mittal SK, Nakao T, Coco G, Taketani Y, Chauhan SK, Dana R.

Sci Rep. 2019 Jun 13;9(1):8617. doi: 10.1038/s41598-019-44973-y.

18.

Methods for Assessing Corneal Opacity.

Dohlman TH, Yin J, Dana R.

Semin Ophthalmol. 2019;34(4):205-210. doi: 10.1080/08820538.2019.1620796. Epub 2019 Jun 12. Review.

PMID:
31188043
19.

Thrombospondin-1 in ocular surface health and disease.

Foulsham W, Dohlman TH, Mittal SK, Taketani Y, Singh RB, Masli S, Dana R.

Ocul Surf. 2019 Jul;17(3):374-383. doi: 10.1016/j.jtos.2019.06.001. Epub 2019 Jun 5. Review.

PMID:
31173926
20.

Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study.

Szczotka-Flynn LB, Maguire MG, Ying GS, Lin MC, Bunya VY, Dana R, Asbell PA; Dry Eye Assessment and Management (DREAM) Study Research Group.

Optom Vis Sci. 2019 Jun;96(6):387-396. doi: 10.1097/OPX.0000000000001387.

PMID:
31116166

Supplemental Content

Loading ...
Support Center